Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02208947 · ClinicalTrials.gov registry record · Phase 3

Consumer Engagement to Increase Advance Care Planning

A Phase 3 study, sponsored by University of Pittsburgh.

Terminated
Registry status
Phase 3
Development phase
77
Enrollment target

NCT02208947: Clinical Trial Phase 3 study, sponsored by University of Pittsburgh.

NCT02208947 is a Phase 3 study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 77 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02208947, a Phase 3 study, was terminated before completion, sponsored by University of Pittsburgh.

TERMINATED
Registry status
Phase 3
Development phase
77 participants
Enrollment target

Study Summary

The specific aims of the project are: 1) to test the effectiveness of consumer-directed financial incentives paired with provider-directed financial incentives, compared to provider-directed financial incentives alone, for increasing advance care planning (ACP) among Medicaid beneficiaries; and 2) to assess perceptions regarding the appropriateness of consumer-directed financial incentives for ACP among study participants. The investigators hypothesize that consumer-directed financial incentives will result in a 15-percentage point absolute increase in the proportion of subjects completing ACP. The investigators do not advance hypotheses about the qualitative component.

Primary Outcome

The primary outcome is the patient discussing their ACP with their provider within 2 months of having received the study advance care planning information packet, measured by the provider submitting an attestation form to Partnership HealthPlan of California to receive their ACP quality incentive payment.

Interventions

  • BEHAVIORAL Consumer financial incentive
  • BEHAVIORAL PREPARE

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2014-04
Est. Completion 2015-02
Phase Phase 3
University of Pittsburgh

1,238 total trials

Why NCT02208947 stopped before completion

NCT02208947 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which Consumer financial incentive is the first listed.

NCT02208947 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02208947 about?

NCT02208947 is a clinical study titled "Consumer Engagement to Increase Advance Care Planning". The specific aims of the project are: 1) to test the effectiveness of consumer-directed financial incentives paired with provider-directed financial incentives, compared to provider-directed financial incentives alone, for increasing advance care planning (ACP) among Medicaid beneficiaries; and 2) t...

What is the current status of trial NCT02208947?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 77 participants. The study started on 2014-04. Estimated completion is 2015-02.

What interventions are being tested in trial NCT02208947?

The interventions under investigation include: Consumer financial incentive (BEHAVIORAL), PREPARE (BEHAVIORAL).

Who is sponsoring clinical trial NCT02208947?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02208947's enrollment target sits among peer trials

77 1771st of 2000 higher than 228 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02127398 · 77 participants · Phase 2

    Stool Transplants to Treat Refractory Clostridium Difficile Colitis

  • NCT04159103 · 77 participants · Phase 1

    Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

  • NCT04683003 · 77 participants · Phase 3

    A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

  • NCT05004116 · 77 participants · Phase 1

    A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02208947, the US trial registry maintained by the National Library of Medicine. NCT02208947 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.